Caladrius CEO Predicts Tenfold Market Cap Rise As Pipeline ‘Validates’ Itself

 
• By Sten Stovall
  
Blood
Caladrius Biosciences develops treatments for ischemic cardiovascular disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cardiovascular

More from Therapy Areas